(.32 X .38) I only need another $40.00 rise and I will break even
Is this $lumbering giant finally awakening from its long $leep?
Nigel Bird, this stock may not go to $40, but $4.00 may be a possibility with the buyout rumors of SALV circulating the Biotech industry and are now just reaching the internet.
There appear to be a few long time disgruntled shareholders of SALV.
If you still hold shares of this company, get ready for your shares to become valuable again like they were in the past.
I don't know if anyone else has heard, but a company called Meridian Diagnostics (KITS) is rumored to have made an offer to purchase Saliva Diagnostics (SALV) in a (1 for 2) or (1 for 3) share purchase. In other words, shareholders of (SALV) would receive 1 share of (KITS) for every 2 or 3 shares of (SALV) that they own.
(KITS) closing bid price today was $7.625. This indicates that Meridian Diagnostics is interested in Saliva Diagnostics at a price between ($2.5416-$3.8125).
FDA APPROVAL OF (SALV)'S RAPID HIV TEST IS THE FOCAL POINT OF THIS BUYOUT.
Meridian Diagnostics (KITS), biz.yahoo.com,
has FDA approval on many excellent rapid diagnostic tests for other infectious diseases. However, it doesn't produce any kind of rapid HIV test. (KITS) buyout of (SALV) would further diversify (KITS) inventory and continue in its vertically integrated acquisition plans.
(KITS) could EXPEDITE THE FDA APPROVAL OF THE (SALV) RAPID HIV TEST.
Saliva Diagnostics (SALV), salv.com, has the best rapid HIV test available. (SALV) has invested over $30 million in researching, developing, and perfecting its product. All that is missing from turning this several million/year product into a several hundred million/year product is the FDA approval. Meridian is in a position to get a fast-track FDA approval for the product.
This is why (KITS) is willing to pay a premium price for (SALV) shares. It's an incredible product that would be used in every hospital, emergency room, health clinic, and a huge home use market. The test only takes ~5 minutes for results compared to a few days for current FDA approved HIV tests. To look at the product:
salv.com
The rumors of the buyout are just hitting the internet and today's volume and price increase of (SALV) is an indication of greatly increased volume and share price in the next few trading days.
This appears to be an incredible momentum trading opportunity with minimal downside and extremely favorable upside potential.
(SALV) has been searching for an alliance to expedite the FDA approval of its rapid HIV test. It appears that Meridian Diagnostics (KITS) has the capability to best utilize this very necessary rapid HIV product. (KITS) buyout appears to be the perfect solution.
Adjusting for a 1 for 10 stock split in August of '98, (SALV) was once valued at $60/share during its IPO days in '93. After suffering a year of the "Reverse Split Syndrome", the asking price closed at today at $.38 . There is nowhere to go but up for (SALV)in the next several trading days.
If you're able to obtain (SALV) shares for under $1.00 on Friday,10-15, you will be very fortunate.
Remember, (SALV) only has 8.11 million outstanding shares and 3.7 million in the public float. This stock will move up very quickly due to the high demand and low supply of shares when the rest of the investing community becomes aware of this incredible buying opportunity. The market makers will probably be ready to pump this stock up in the next few days.
Since I just heard about this buyout rumor on Tuesday 10-12-99,I've spent 12 hours researching this information and (SALV) appears poised to blastoff tomorrow after the opening bell.
Best of luck to all of you reading this for the first time.
Ron |
